Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 4 Summary of Meta-Proportions on adverse effects from different modalitites of catheter ablation

From: Effectiveness and safety of different types of ablation modalities in patients with atrial fibrillation: a bayesian network meta-analysis from randomized controlled trials

Adverse Effects

LPLD Radiofrequency

HPSD Radiofrequency

vHPSD Radiofrequency

Cryoballoon

Laser Balloon

k

Prop

95% CI

k

Prop

95% CI

k

Prop

95% CI

k

Prop

95% CI

k

Prop

95% CI

Anaphylactic shock

1

0

0.00; 1.00

-

-

-

-

-

-

-

-

-

-

-

-

Arteriovenous fistula

3

1.68

0.00; 27.58

2

0

0.00; 1.00

-

-

-

-

-

-

-

-

-

Atrial flutter / tachycardia

8

9.75

4.94; 18.31

1

0

0.00; 1.00

1

0

0.00; 1.00

4

1.56

0.60; 3.99

2

7.8

0.31; 69.83

Atrioesophageal fistula

3

0

0.00; 1.00

-

-

-

-

-

-

1

0

0.00; 1.00

1

0

0.00; 1.00

Cardiac tamponade

14

1.15

0.71; 1.86

5

0.44

0.14; 1.34

2

0.83

0.00; 1.00

3

0.26

0.01; 5.23

2

0.84

0.00; 98.6

Chest infection

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Death

9

0.32

0.03; 3.82

1

0

 

1

0

0.00; 1.00

1

0.53

0.13; 2.11

2

0

0.00; 1.00

Diaphragm paralysis

4

0.47

0.05; 4.31

-

-

-

-

-

-

-

-

-

1

3.53

1.59; 7.63

Femoral pseudoaneurysm

5

1.05

0.26; 4.11

1

0.58

0.08; 3.99

-

-

-

-

-

-

-

-

-

Groin hematoma/bleed

13

2.41

1.30; 4.44

4

0.6

0.20; 1.84

2

0

0.00; 1.00

6

3.21

0.96; 10.22

1

0

0.00; 1.00

Heart failure

4

0.77

0.1; 5.51

2

0.5

0.00; 47.57

-

-

-

-

-

-

-

-

-

Myocardial infarction

4

0.32

0.01; 7.25

-

-

-

-

-

-

-

-

-

2

0.41

0.00; 99.99

Pericardial effusion

5

1.07

0.31; 3.62

-

-

-

1

6.67

0.93; 35.2

4

0.71

0.11; 4.34

-

-

-

Phrenic nerve injury

8

0.09

0.01; 0.99

2

0.47

0.00; 58.35

-

-

-

11

4.14

2.92; 5.83

3

1.97

0.23; 15.1

Pneumonia

2

4.17

0.00; 97.79

1

0

0.00; 1.00

-

-

-

-

-

-

-

-

-

Postinterventional pericarditis

-

-

-

4

1.42

0.12; 14.70

-

-

-

-

-

-

1

2.86

0.40; 17.69

PV stenosis

9

0.47

0.08; 2.82

2

0.38

0.00; 99.92

1

0

0.00; 1.00

1

0

0.00; 1.00

1

0

0.00; 1.00

Sepsis, abscesses, or endocarditis

8

0.70

0.09; 5.48

1

3.23

0.45; 19.64

-

-

-

1

0.75

0.11; 5.14

1

2.86

0.4; 17.69

Stroke

11

0.44

0.18; 1.10

3

0.09

0.00; 6.02

1

0

0.00; 1.00

1

0.56

0.05; 6.33

3

1.83

0.27; 11.51

Transient ST elevation

-

-

-

1

0

0.00; 1.00

-

-

-

1

5.88

0.82; 32.03

1

5.71

1.43; 20.16

TIA

8

0.77

0.32; 1.87

-

-

-

-

-

-

3

0.18

0.00; 11.77

2

0.37

0.00; 99.92

  1. LPLD, low power long duration; HPSD, high power short duration; vHPSD, very high power short duration
Back to article page

Journal of Cardiothoracic Surgery

ISSN: 1749-8090

Contact us